Bayer cuts dividends to legal minimum to reduce debt
FRANKFURT (Reuters) -German drugmaker Bayer said on Monday that it was amending its…
N2:PHAR
Biogen sees flat 2024 sales, pick up in Alzheimer’s drug demand
By Manas Mishra and Sriparna Roy (Reuters) -Biogen on Tuesday forecast flat 2024 product…
US judge refuses to block Medicare from negotiating drug prices
By Brendan Pierson (Reuters) -The U.S. government's Medicare health insurance…
Big Pharma bets on AI to speed up clinical trials
By Natalie Grover and Martin Coulter LONDON (Reuters) - Major drugmakers are using…
J&J expects double-digit 2023 profit growth after Kenvue spinoff
(Reuters) -Johnson & Johnson on Wednesday forecast double-digit profit growth for…
AbbVie trims forecast for Humira sales drop on favorable coverage
By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Thursday trimmed its 2023 view for…
Exclusive-US to build $300 million database to fuel Alzheimer’s…
By Julie Steenhuysen CHICAGO (Reuters) - The U.S. National Institute on Aging (NIA) is…